Company Monitoring Page for Roche

latest headlines for company on cafepharma

Bristol-Myers to license two drugs to Biogen, Roche
Yahoo/Reuters
Thu, 04/13/17 - 11:52 am
Tags:
Bristol-Myers Squibb, Biogen, Roche, BMS-986168, BMS-986089
4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't
Motley Fool
Wed, 04/12/17 - 10:33 am
Tags:
Roche, Tecentriq, Perjeta, HER-2 postive breast cancer, Ocrevus, MS, multiple sclerosis, diagnostics, generics, biosimilars
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Mon, 04/10/17 - 11:09 am
Tags:
Roche, Genentech, Pfizer, Xalkori, Alecensa, non-small cell lung cancer
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
Tags:
JNJ, Actelion, Darzalex, Novartis, Cosentyx, Jakavi, Lucentis, Tasigna, Roche, Venclexta, Tecentriq, emicizumab
Why Roche's New Drug Is Bad News For Biogen
Barron's
Sun, 04/9/17 - 12:20 pm
Tags:
Roche, Biogen, Ocrevus, multiple sclerosis, MS, Tysabri, Tecfidera
The cost of cancer: new drugs show success at a steep price
Yahoo/Reuters
Mon, 04/3/17 - 09:13 am
Tags:
cancer, Bristol-Myers Squibb, Merck, Roche
Roche secures FDA approval for Ocrevus for two types of MS
BioPharma Dive
Tue, 03/28/17 - 11:56 pm
Tags:
Roche, Ocrevus, FDA, ocrelizumab, MS, multiple sclerosis
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Yahoo/Reuters
Thu, 03/23/17 - 09:32 am
Tags:
Sanofi, Roche, GSK, FDA, Ocrevus, MS, Dupixent, eczema, generics, Advair, Mylan Labs
Roche trims workforce in struggling U.S. diabetes market
BioPharma Dive
Thu, 03/16/17 - 10:32 pm
Tags:
Roche, layoffs, diabetes
Roche and Mylan settle a scrap over Herceptin, clearing path to a global launch of a knockoff drug
Endpoints
Mon, 03/13/17 - 10:13 am
Tags:
Roche, Mylan Labs, Herceptin, Perjeta, breast cancer
Roche is bringing back gantenerumab from the dead, taking another stab at Alzheimer’s PhIII
Endpoints
Tue, 03/7/17 - 10:29 am
Tags:
Roche, gantenerumab, Alzheimer's disease, clinical trials
Roche and Novartis CEOs nab all-but-matching pay of 12M francs for 2016
Fierce Pharma
Fri, 03/3/17 - 09:18 am
Tags:
Roche, Novartis, Pharma CEOs, executive pay, Severin Schwan, Joe Jimenez
Roche shares spike as PhIII breast cancer combo with Perjeta scores a success, Puma takes a beating
Endpoints
Thu, 03/2/17 - 10:41 am
Tags:
Roche, breast cancer, clinical trials, Perjeta
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Bloomberg
Thu, 03/2/17 - 10:16 am
Tags:
Alzheimer's disease, drug development, Roche, Merck, Eli Lilly, Biogen
Roche to start new trial of AC Immune drug against Alzheimer's
Yahoo/Reuters
Tue, 02/28/17 - 10:05 am
Tags:
Roche, AC Immune, Alzheimer's disease, clinical trials, crenezumab
Roche confirms patient death in ACE910 PhIII hemophilia trial, spurring new questions about top blockbuster hopeful
Endpoints
Fri, 02/24/17 - 11:39 am
Tags:
Roche, ACE910, hemophilia, clinical trials
Should Merck, BMS Fear Roche's Drug Becoming The I-O King?
Seeking Alpha
Fri, 02/24/17 - 09:10 am
Tags:
Merck, Bristol-Myers Squibb, Roche, immuno-oncology, Tecentriq
The FDA opens an inside track to let Novartis race ahead on Zykadia as Roche rivalry heats up
Endpoints
Thu, 02/23/17 - 09:23 am
Tags:
FDA, Novartis, Zykadia, ALK-positive non-small cell lung cancer, non-small cell lung cancer, Roche, Alecensa
Roche says Phase II trial supports twin treatment for kidney cancer
Yahoo/Reuters
Sat, 02/18/17 - 02:35 pm
Tags:
Roche, kidney cancer, Tecentriq
Roche gears up to enter loaded hemophilia A drug market
Medical Marketing and Media
Thu, 02/16/17 - 03:11 pm
Tags:
Roche, hemophilia A, emicizumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.